Trend Breakdown

The Evidence

Does oxytocin nasal spray actually increase trust?

A single 2005 experiment turned oxytocin into the so-called trust hormone and built a wellness market around nasal sprays sold as social shortcuts. The peer-reviewed record since then, including the largest oxytocin trial ever run, tells a far more cautious story about what the spray can do.

Updated Published 2 Aug 2026 · Last reviewed 2 Aug 2026 · 4 min read · 5 sources

Skip to the verdict ↓

Trend Science
Breakdown

Evidence-graded series

02What's being claimed

The claim circulating in biohacking and dating-advice circles is that a few sprays of over-the-counter oxytocin up the nose can make other people trust you more and deepen your own sense of connection, turning a hormone your body already makes into something you can buy and dose before a date or a negotiation.

Oxytocin is a genuine neuropeptide, released during childbirth, breastfeeding and physical closeness, and animal research has long tied it to pair-bonding and parental care. In 2005, Kosfeld and colleagues gave 128 men a dose of intranasal oxytocin before a monetary trust game and found they handed over more money to a stranger than men given a placebo ¹. The finding ran in Nature, one of the most visible journals in science, and offered something rare: a single hormone that seemed to switch trust on.

That combination, real biology plus one dramatic result plus a nasal spray anyone could order online, was built for spreading. Journalists and popularisers branded oxytocin the love hormone or the moral molecule, and the label stuck long after the original claim came under scrutiny. Biohacking forums and dating-advice accounts now sell the spray as a pre-date ritual, promising the same trust boost Kosfeld's participants reportedly showed.

Origin

Kosfeld et al. 2005

A Nature trust-game study on 128 men reported intranasal oxytocin raised monetary trust transfers.

→

Vector

Love hormone framing

Popular science press and public talks branded oxytocin the trust and bonding molecule.

→

Spike

Biohacking dating-advice trend

Over-the-counter oxytocin sprays are now marketed on social platforms as instant trust shortcuts.

"People spray oxytocin before dates, before negotiations, before anything where they want someone else's guard to drop, because one famous study showed it can make strangers hand over their money."

- representative of the claim as it circulates in biohacking and dating-advice communities

03The evidence verdict

HiPerformance Culture The Evidence · Trend Breakdown

Verdict

One 2005 study launched the oxytocin trust craze; failed replication and a mechanism problem sink it.

This trend lands here

Evidence for the claim: 22/100 (Low) 5 sources cited · 1 foundational trust-game study, 1 critical review, 1 mechanism paper, 1 large RCT, 1 adverse-events meta-analysis · 2005-2021 · how we grade ↓

Every line below is graded by the strength of the evidence behind it.

Gold: strongest available evidence
Silver: solid, not decisive
Bronze: preliminary or indirect

how we grade ↓

✓

What holds up

✓

A widely cited 2005 trust-game experiment found that intranasal oxytocin increased participants' willingness to trust another person with money.¹

SilverSupporting study: Kosfeld 2005

✓

Nasal oxytocin sprays used at typical clinical trial doses are generally well tolerated, producing mild, self-limiting side effects such as nasal discomfort and thirst.⁵

SilverSupporting study: Cai 2018

What doesn't

A systematic critical review of the oxytocin-trust literature found the original effect has not replicated reliably, with no robust convergent evidence that oxytocin causes human trust.²

GoldSupporting study: Nave 2015

Very little intranasal oxytocin appears to reach the brain at meaningful concentrations; most of the dose simply raises peripheral blood levels, undermining the proposed brain-trust mechanism.³

GoldSupporting study: Leng 2016

A large 24-week randomised trial in children and adolescents found daily intranasal oxytocin produced no improvement in social interaction compared with placebo.⁴

GoldSupporting study: Sikich 2021

Cai et al. found aggression and seizures at similar rates on oxytocin and placebo, calling the drug well tolerated; the data is from clinician-dosed, pharmaceutical-grade use in autism, not unsupervised over-the-counter spray.⁵

Safety-criticalSilverSupporting study: Cai 2018

04So what do you actually do

If you want more trust in your life, the evidence points away from a spray bottle.

The evidence supports scepticism about the over-the-counter product, not clinical oxytocin use.

01Skip over-the-counter oxytocin spray as a trust or dating shortcut; the founding study has not replicated.

02Build trust through repeated, reciprocal behaviour, such as keeping promises and following through, rather than a supplement.

03If you are considering prescribed oxytocin for a diagnosed condition, use it only under clinical supervision.

04Treat love hormone marketing claims as a red flag; no study has tested the unregulated products actually sold online.

05The studies

Tier inputs Design quality Measurement precision Causal clarity Replication value

GoldThe strongest evidence available for the specific line it supports: typically systematic reviews, meta-analyses, or randomised trials, or definitive mechanistic work where the line is a mechanistic claim.

SilverSolid but not decisive support: controlled or observational studies, or direct evidence that is small or not yet replicated.

BronzePreliminary or indirect signals; suggestive, never sufficient on their own.

A per-source tier is displayed only when all four axis scores and the weights and thresholds that compute the tier are recorded. Sources without those inputs remain unscored; no tier is inferred from a design label, sample-size phrase, or existing editorial chip. Every source still discloses its design and a resolvable DOI.

n=128 participants in the founding trust-game experiment

Randomised placebo-controlled trust-game experiment · n=128

Kosfeld et al. Nature · 2005

Men given intranasal oxytocin before a monetary trust game transferred significantly more money to a trustee than men given placebo, and the effect held even after accounting for general risk tolerance, which is what made the result so striking to behavioural scientists at the time.

doi:10.1038/nature03701 Verify ↗

Contested : Widely cited as proof oxytocin causes trust, but the effect has proven difficult to replicate at scale.

Critical review of intranasal, plasma-correlation and genetic-polymorphism studies

Nave, Camerer & McCullough Perspectives on Psychological Science · 2015

Reviewing three independent lines of evidence, Nave and colleagues found the original trust-game result has not replicated well and that plasma-oxytocin assays used in supporting studies carry serious measurement reliability problems, weakening the evidence base behind the trust-hormone narrative.

doi:10.1177/1745691615600138 Verify ↗

Mechanistic and pharmacokinetic review

Leng & Ludwig Biological Psychiatry · 2016

Leng and Ludwig show that only a small fraction of an intranasal oxytocin dose reaches cerebrospinal fluid, while peripheral blood concentrations rise to supraphysiological levels, raising doubts about the proposed direct pathway from nose to brain to trust.

doi:10.1016/j.biopsych.2015.05.003 Verify ↗

n=290 participants, no significant benefit over placebo

Phase 2 randomised, double-blind, placebo-controlled trial · n=290

Sikich et al. New England Journal of Medicine · 2021

In the largest oxytocin trial to date, 24 weeks of daily intranasal oxytocin produced no significant improvement in social interaction outcomes among children and adolescents with autism spectrum disorder compared with placebo, the strongest available evidence against the trust-hormone narrative's real-world claims.

doi:10.1056/nejmoa2103583 Verify ↗

5 serious adverse events reported across pooled trials

Systematic review and meta-analysis of adverse events · n=223

Cai, Feng & Yap Psychiatry and Clinical Neurosciences · 2018

Pooling five randomised trials, the authors found common adverse events such as nasal discomfort, tiredness and irritability were not statistically linked to oxytocin allocation, but rare serious events including aggression and seizures were reported in both arms.

doi:10.1111/pcn.12627 Verify ↗

06The verdict triad

Claim

Sniffing oxytocin buys instant trust

The pitch is simple: a few sprays before a date or a negotiation and the other person opens up faster, echoing the 2005 finding that oxytocin made men hand over more money in a laboratory trust game.

Consequence

The founding study never replicated

A critical review of the wider evidence found the original trust-game effect has not held up, and pharmacokinetic work shows the spray likely never reaches the brain at the levels marketing implies it does.

Lever

Build trust through behaviour, not sprays

Consistent, reciprocal behaviour remains the only evidence-backed route to trust and connection. Anyone weighing therapeutic oxytocin for a diagnosed condition should treat it as a medical decision made with a clinician, not a wellness purchase.

07The protocol

08What to do next

What to do next

Want a trust-building method backed by more than one study?

Our Social Trust & Connection Assessment maps where your habits actually build or erode trust, and points towards protocols with a stronger evidence base than a spray bottle.

Take the assessment

09Share & references

Update log

2 Aug 2026Initial publication, 5 peer-reviewed sources reviewed, 2005-2021.

20 Aug 2026Machine layer added: structured claim data with an authored veracity verdict, accessible meter with stated evidence position, grading disclosure, and related links and calls to action wired to live destinations.

Next reviewDue by February 2027, or earlier if a new controlled trial or systematic review lands.

Bibliography · every source, resolvable

01Kosfeld, M., Heinrichs, M., Zak, P.J., Fischbacher, U. & Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435(7042), 673-676. doi:10.1038/nature03701 Verify ↗

02Nave, G., Camerer, C. & McCullough, M. (2015). Does Oxytocin Increase Trust in Humans? A Critical Review of Research. Perspectives on Psychological Science, 10(6), 772-789. doi:10.1177/1745691615600138 Verify ↗

03Leng, G. & Ludwig, M. (2016). Intranasal Oxytocin: Myths and Delusions. Biological Psychiatry, 79(3), 243-250. doi:10.1016/j.biopsych.2015.05.003 Verify ↗

04Sikich, L., Kolevzon, A., King, B.H., McDougle, C.J., Sanders, K.B., Kim, S., Spanos, M., Chandrasekhar, T., Trelles, M.P., Rockhill, C.M., Palumbo, M.L., Witters Cundiff, A., Montgomery, A., Siper, P., Minjarez, M., Nowinski, L.A., Marler, S., Shuffrey, L.C., Alderman, C., Weissman, J., Zappone, B., Mullett, J.E., Crosson, H., Hong, N., Siecinski, S.K., Giamberardino, S.N., Luo, S., She, L., Bhapkar, M., Dean, R., Scheer, A., Johnson, J.L., Gregory, S.G. & Veenstra-VanderWeele, J. (2021). Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. New England Journal of Medicine, 385(16), 1462-1473. doi:10.1056/nejmoa2103583 Verify ↗

05Cai, Q., Feng, L. & Yap, K.Z. (2018). Systematic review and meta‐analysis of reported adverse events of long‐term intranasal oxytocin treatment for autism spectrum disorder. Psychiatry and Clinical Neurosciences, 72(3), 140-151. doi:10.1111/pcn.12627 Verify ↗